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Six novel polymorphic short sequence repeats were
identified and localized on the linkage map of human
chromosome 21 by genotyping the CEPH reference
pedigrees. One of these markers, the tetrameric
(AAAG)n repeat D21S1245, was found to be hyper-
mutable. In the DNAs from lymphoblastoid cell lines
of members of the 40 CEPH families a total of 18 new
alleles were detected. These new alleles, sometimes
appearing In mosaic forms, arose equally In paternal
and maternal DNAs, and could be equally larger or
smaller than the alleles from which they were derived.
The larger alleles of D21S1245 are more prone to be
converted to new alleles. None of the new alleles
with mosaicism were present in the corresponding
genomic blood DNA, and therefore originated during
or after the establishment of the lymphoblastoid cell
lines; half of the new alleles without mosaicism were
also found in genomic blood DNA of the appropriate
CEPH individuals. The range of germline mutation
rate observed in the 716 meioses examined was 0.56-
1.4x10~2; the range of somatic mutations observed
in the 405 cell lines examined was 1.96-3.46x10~2.
This is one of the most hypermutable microsatelllte
repeat polymorphism in the human genome detected
to date. D21S1245, is highly polymorphic (hetero-
zygosity of 0.96) and maps between D21S231 and
D21S198.
Extensive linkage maps for all human chromosomes have now
been developed and the average resolution of these maps
across the entire genome is now less than 5 cM (3-5); for
some chromosomes, like chromosome 21, this resolution is
less than 2 cM (6,7). The SSRs are thought to evolve very
rapidly as many alleles are observed at each locus, leading to
their high heterozygosity. Most of the SSRs show new mutant
alleles, recognized as expansion or contraction of the number
of repeat units at a rate of 1.2X 10~3 per locus per gamete per
generation (8). Such mutation rates are significantly higher for
tetranucleotide repeats (2.1 X 10~3) than for dinucleotide repeats
(0.56X10"3) (8). Notwithstanding, these levels of mutation
rates are still low to permit their use as markers in linkage
analysis for mapping disease phenotypes. However, a few loci
have a much higher mutation rate. For example, Mahtani and
Willard (9) reported that the tetranucleotide repeat DXS981
showed a mutation rate of 1.5 X10"2 (four new mutations in
274 transmissions), which is approximately 10 times higher
than the average. As part of our ongoing effort to develop a
high-resolution linkage map for chromosome 21 we report
here the identification of a highly informative and hypermutable
locus, D2IS 1245. Although this and other hypermutable
markers may not be ideal for linkage analyses, they are critical
in studies aimed at understanding the instability of DNA
markers, such as the genomic instability recognized in the
hereditary non-polyposis colon cancer (HNPCC) (10-12), or
the specific locus instability as seen by the expansion of
trinucleotide repeats associated with some human disorders
such as fragile X syndrome (13).
INTRODUCTION
The use of DNA polymorphisms has greatly enhanced the
ability to map monogenic and complex phenotypes and to
explore the human genome in health and disease. In recent
years a large number of highly polymorphic loci have been
identified in the human genome. These polymorphisms are
almost exclusively due to variation of short sequence repeats
(SSR) of two to a few nucleotides, whose different alleles can
be identified by the polymerase chain reaction (PCR) (1,2).
RESULTS
Mapping of six SSRs on chromosome 21
A total of six new polymorphic markers were mapped to
human chromosome 21; Table 1 shows their map location and
some of their characteristics. Two markers were cloned after
probing the genomic library with the (GT)15 oligomer, two
with the (AGAT)5, and two with the (AAAG)5 repeat. The
heterozygosity of these markers ranges from 31 to 96%.
The oligonucleotide primers used for their amplification and
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Table I. Characteristics of six new polymorphic markers on human chromosome 21
Marker Lab name Repeat
type
Oligonucleotides Genebank Size Alleles
# orig STS in 8 ceph
Obs het Close
linkage
e Lod score
D2 IS 1238
D2ISI239
D2ISI280
D2ISI244
D2IS1245
D2IS1246
UT409
UT489
UT706
UT76I
UT762
UT973
(CA)n
(CA)n
(AAAG)n
(AGAT)n
(AAAG)n
(AGAT)n
TGCAGAGTGTACATGCCTG
GTGCTGCATGGATGAAAGG
ACAATTTCCATGCAGGAAAACT
TTGGAAAAACATCAGTCATGAG
AGTGGGCATCAAAATTTGGA
GAAGAAATAGGAGCCATAAAGC
GTCCCCATATTGATAAACTATT
ATGAATAGGGGATATGCTGG
GTCAGTATTACCCTGTTACCA
GTTGAGGATTTTTGCATCAGT
GATAAAGTAGACAGATAAACA
GGATTATAATTCAAGATGAGAT
LI 6245
LI 6265
L31752/3
L16331
LI 6332
LI6366
217
225
370
247
289
400
2
5
9
5
19
7
31%
62%
94%
62%
96%
50%
D21S267
D21S259
D21S2I6
D21S2I8
D21S224
D21S216
APP
D21S222
D21S2I2
D2IS198
D21S168
D21S23I
0.00
0.00
0.00
0.00
0.02
0.02
0.00
0.00
0.03
0.02
0.00
0.00
11.14
10.23
12.94
10.83
25.07
16.15
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Figure 1. Examples of novel alleles of DNA marker D21S1245. Alleles are numbered per family and the new alleles are shown. For detailed description, see text.
GenBank accession numbers for their nucleotide sequences
are included in the table, as are selected two-point lod scores
for the most closely linked markers. The locations on the
genetic map with odds of 1000:1 against inversion of adjacent
loci, relative to markers of the most recent linkage maps of
chromosome 21 (6,14) are as follows: D21S1245 maps between
D21S231 and D21S198; D21S1246 between D21S156 and
D21S168; D21S1238 between D21S1252 and D21S156;
D21S1280 and D21S1239 between D21S224 and IFNAR; and
D21S1244 between D21S265 and D21S232.
Tbble 2. Characteristics of de novo alleles of marker D2IS 1245
Paternal source
Size relative to parental
Appearance
Paternal
Maternal
Smaller
Larger
Single band
Mosaicism
9
9
8
9
13
5
50%
50%
47%
53%
72%
28%
Detection of de novo alleles for marker D21S1245
One of the polymorphic SSRs, D21S1245, which was identified
after screening the library with (AAAG)5 showed an unusually
high number of de novo alleles as revealed by initially
genotyping the DNAs of lymphoblastoid cell lines of the
members of eight CEPH families; the DNAs of all 40 CEPH
families were subsequently used for further analysis and
mapping. Figure 1 shows examples of de novo alleles for
marker D21S1245 in DNAs of the CEPH lymphoblastoid cell
lines. In family 884, as shown in Fig. 1A, the individual
designated Fla has allele 3, which is not present in either her
father or mother; the second allele, 1, is inherited from the
mother. Non-paternity was excluded in this case with a
high degree of certainty as: (i) more than 60 other highly
polymorphic markers on chromosome 21 and (ii) hundreds of
other SSRs from all other chromosomes have been studied in
this family without evidence of non-patemal inheritance of
polymorphic alleles. Sample mix-up was also excluded. The
most probable explanation for the appearance of allele 3 in
this case is the mutation of paternal allele 4 to a shorter allele
3. The size difference between alleles 4 and 3 was four
nucleotides, as estimated from acrylamide gel electrophoresis
and confirmed by nucleotide sequencing.
In another example (Fig. IB), the offspring in family 1420,
designated Fib, shows alleles 1 and 3, both of which are
present in the father; no alleles inherited from the mother were
observed. However, uniparental disomy appears to be an
unlikely explanation as more than 60 other SSR chromosome 21
markers examined in this family showed biparental inheritance.
The most likely explanation is that allele 4 of the mother
underwent a de novo mutation to a new shorter allele 3 which
is the same size as paternal allele 3.
In some cases de novo alleles occurred as mosaics with
their normal counterparts. An example is shown in Fig. 1C.
Individual designated Fid from family 13293 shows inheritance
of allele 2 from the mother; however, the inherited paternal
allele 3 had probably suffered a de novo mutation to allele 4
during mitosis so that both of these alleles were present in the
DNA of individual Fid. It is noteworthy that in this family
allele 2 of the mother was not present in the maternal
grandparents, suggesting that allele 2 was probably the result
of a mutation in one of the maternal grandmaternal alleles 5
or 7. In this case it is not possible to specify the allele from
which the mutation originated.
All members of the 40 CEPH families have been genotyped
in the search for de novo alleles for marker D21S1245. A total
of 18 such de novo mutant alleles were observed (DNAs from
individuals 13293-02, 13293-06, 13294-08, 1331-01,
1331-07, 1408-03, 1418-01, 1408-04, 1420-07, 1346-05,
1349-07, 1350-06, 1413-10, 104-04, 102-10, 884-10,
37-06, 12-08). Among these, five of 18 (28%) were in mosaic
form. Table 2 shows additional characteristics of these events.
The origin of the de novo mutant alleles was paternal in nine
(50%) and maternal in nine (50%) cases, indicating that there
was not a preferential sex of origin for these mutations. The
size of the de novo allele was smaller in eight (47%) and
larger in nine (53%) cases. Again, no trend towards expansion
or contraction was observed. The parental source of the de novo
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Figure 2. Comparison of PCR results for individuals with new alleles in CEPH DNAs from lymphoblastoid cell lines with different dates of extraction. Samples
from the laboratory of S.E.A. are shown on the left and from those kindly supplied from the laboratories of Drs M.Petersen and E.W.Jabs are shown on the
right of each pair. The dates of DNA extraction are also shown. Arrows indicate the de novo mutant alleles. In the cases of mosaisism (e.g. 13293-06, 1331-
01, 102-10), only the novel/mutant allele is shown by arrow.
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Figure 3. Distribution of alleles of locus D21S1245. The striped bars represent the frequency of each allele in the 80 unrelated parents of the CEPH collection.
The black bars represent the frequency distribution of those D21S1245 alleles from which the de novo alleles were originated.
allele was assigned by studying the inheritance of alleles in a
given pedigree and in some cases by sequence analysis. The
parental allele that was closer in size to the de novo allele was
considered to be the one modified to produce the new allele;
in a considerable number of cases the assignment was done
after sequencing of the individual new allele and its potential
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progenitors. Almost all (16 of 18) of the new alleles were
checked in the individuals' CEPH DNAs from lymphoblastoid
cell lines extracted on two different dates. As shown in Figure
2, no difference was found when DNA samples of the CEPH
lymphoblastoid cell lines, extracted on different dates, are
compared. In particular, the mosaic cases were similar in
both samples (compare for example the similar pattern of
lymphoblastoid line DNAs from individual 1331-01 extracted
on June 24, 1986 and May 30, 1985).
Mosaicism for de novo alleles can result from the establish-
ment or propagation of lymphoblastoid cell lines (8). We
therefore compared the D21S1245 genotypes in genomic DNA
(samples kindly provided by Dr James Weber, Marschfield,
WI) and the corresponding lymphoblastoid cell line DNA in
12 of 18 cases with de novo alleles. In the five cases with
mosaicism we examined, the de novo allele was not found in
the genomic DNA, indicating that the de novo alleles originated
at the establishment or during the propagation of the cell lines.
In the seven cases of de novo non-mosaicism alleles we
examined, the genomic DNA from blood showed the novel
alleles in four cases; in the remaining three cases the genomic
DNA from blood did not show the de novo alleles. Although
the data are limited to available blood DNAs, this result
suggests that in about half of the non-mosaic cases generation
of the de novo alleles also occurred in the lymphoblastoid
cell lines.
In order to determine whether the likelihood of generation
of de novo alleles is the same for all sizes of D21S1245 alleles,
we compared the distribution of the D21S1245 alleles from
all CEPH members with that of those alleles that generated
de novo forms. This comparison was done because we noticed
that the modified allele was almost always the larger one from
an individual heterozygote at locus D21S1245. The results of
this comparison are shown in Fig. 3. It is apparent that there
is a difference between the two distributions of alleles. Most
of the de novo alleles (>75%) originate from alleles larger
than allele 16 (300 nt), while only 30% of the alleles in the
CEPH unrelated individuals are larger than allele 16. In fact,
classifying alleles by the median de novo allele size (#17)
shows a highly significant difference (x2 = 10.2, 1 d.f.,
0.001</><0.005).
In order to examine the potential contribution of chromo-
somal sequence environment in the generation of new alleles,
we examined the genotypes of D21S231 and D21S198, the
two markers on either side and most closely linked to
D2 IS 1245, and compared the distribution of their polymorphic
alleles with that of those alleles in cis with the de novo
mutations. This was possible because the genetic distances
between D21S231-D21S1245 and D21S198-D21S1245 are
less than 2 cM; thus polymorphic haplotypes could be
developed for these three loci in the CEPH individuals.
The histograms for this analysis are shown in Figure 4a,b.
Comparison of the histograms by the median de novo allele
size does not reveal significant differences, suggesting that
alleles at the most closely linked loci D21S231 (median =
allele 1; x2 = 0 0 4 . 1 d.f., non-significant) and D21S198
(median = allele 4; x2 = 2.67, 1 d.f., non-significant) are not
involved in the mechanism of the generation of de novo alleles.
Perhaps the study of additional loci that map closer to
D21S1245 will be necessary to rule out involvement of ex-
acting sequences in the new mutation mechanism(s).
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Figure 4. (a) Distribution of alleles of locus D21S123 in unrelated individuals
of the CEPH families. The striped bars represent the distribution of alleles in
the 80 unrelated parents of the CEPH collection. The black bars represent the
frequency distribution of those D21S231 alleles in cis with the de novo
D21S1245 alleles. (b) Distribution of alleles of locus D21S198 in unrelated
individuals of the CEPH families. The striped bars show the distribution of
alleles in the 80 unrelated parents of the CEPH collection. The black bars
show the frequency distribution of those D21S198 alleles in cis with the
de novo D21S1245 alleles.
Sequence analysis of D21S1245 polymorphic alleles
Nucleotide sequence analysis of selected polymorphic alleles
from different CEPH DNAs was necessary to determine the
origin of the de novo allele in some cases and to understand
the nature of the polymorphic variability. Sequence analysis
revealed that PCR products of the same apparent size are not
necessarily the same alleles. The DNA sequence amplified
using the D21S1245 oligonucleotide primers contains two
units of short sequence repeats; the first *unit is a (AAAG)n
which after an irregular short (GA)n area is followed by either
another (AAAG)n region or by a long (GA)n region. Both
the tetranucleotide and dinucleotide repeats as well as the
connecting region can be polymorphic. It is therefore not
surprising that although this SSR was identified by screening
with an (AAAG)n oligonucleotide probe, the differences among
alleles can be two nucleotides rather than four given the
polymorphic variability of the (GA)n region in certain indi-
viduals.
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DISCUSSION
In this study we describe the mapping of six SSR polymorphic
loci on human chromosome 21 and the identification of a
tetrameric repeat polymorphic marker, D21S1245, that displays
a considerable degree of new mutations in the CEPH families.
It is important to distinguish between germline and somatic
de novo mutations in order to derive figures for mutation
frequencies. Mutations can be safely classified as germline
mutations if they are: (i) clonal (non-mosaic) and (ii) either
shown to be present in blood cells, or shown to be in the
germline by virtue of transmission (as it is the case in the
de novo allele in the mother of family 13293 in Fig. 1).
Mutations in (i) mosaic form or (ii) not present in blood DNA
can be classified as somatic events. As some of the mutations
observed in the sample cannot be absolutely categorized, the
possible ranges of germline and somatic mutation rates in the
40 CEPH pedigrees are given below. Among the 18 mutations
observed there were eight confirmed somatic events and four
confirmed germline events. The possible range of germline
mutation rate observed in the 716 meioses examined is therefore
between four of 716 (0.56X1CT2) and 10 of 716 (1.4X10"2).
The possible range of somatic mutations observed in the 405
cell lines examined is between eight of 405 (1.96X 10~2) and
14 of 405 (3.46X10"2).
Weber and Wong (8), studying the mutation rate of SSRs
in 28 markers on human chromosome 19, observed an average
mutation rate of 1.2X 10~3 per gamete per generation (approxi-
mately 20 000 parent-offspring allele transmissions were
studied); tetranucleotide repeats showed a significantly higher
average mutation rate (2.1 X 10~3) than did dinucleotide repeats
(5.6X10"4). Weissenbach et al. (3), in their examination of
more than 105 parent-offspring allele transmissions, observed
a mutation rate of 10~3. Mclnnis et al. (6) observed a mutation
rate of 0.7X10"3 for 43 PCR markers on chromosome 21 in
their analysis of approximately 15 000 parent-offspring allele
transmissions. In the Weber and Wong study (8), the majority
of the confirmed new mutations occurred during or after the
transformation of lymphoblastoid cells; they observed 21 new
mutations in vivo and 26 events in vitro. In our study, eight
of the 18 new mutational events apparently occurred in vitro
(in somatic cells), four of 18 events in vivo (in the germline)
and for six the origin of the new mutation could not be
determined due to the lack of appropriate blood genomic DNA
samples. It is therefore apparent that in the case of locus
D21S1245 most of the de novo alleles analyzed occurred
in vitro.
Few SSR polymorphic markers with elevated new mutation
rates have been reported. Among those are DXS981, with
1.5% (four of 274 transmissions) (9), and D19S244 with 0.8%
new mutation rate (8). Both of these loci were polymorphic
due to variable tetranucleotide repeat (GATA)n and both had
heterozygosities of at least 0.86 with more than 10 alleles
each. A short sequence repeat FRAXAC2 that maps within
the FMR-1 gene on Xq27.3 has been found to have a new
mutation rate of 3.3% but only among fragile X maternal
meioses (15); no new mutations in this gene were found in
160 meioses from members of the CEPH pedigrees.
The new mutation rate of two VNTRs (variable number of
tandem repeats) exceeds that of the SSRs discussed above.
Locus D1S7, comprised of variable numbers of tandem 9
mers, shows a - 5 % new mutation rate (16) and locus CEB1
displays a -15% rate of new mutations, exclusively in male
meiosis (17).
In spite of their high degree of heterozygosity, rare poly-
morphic systems with a high new mutation rate, such as
D21S1245 described here, may not be ideal markers for linkage
mapping of disease phenotypes, as the appearance of new
alleles can complicate interpretation of analyses. On the other
hand, such markers may be useful, for example, in evaluating
the genomic instability of tumor DNA. Genomic instability
for some sporadic and hereditary cancers of the colon, as
defined by the appearance of new alleles for short sequence
repeat polymorphisms, has been recently recognized (10-12).
Subsequently, similar genomic instability has been shown to
exist, albeit less commonly, in breast and ovarian tumors as
well as in soft tissue sarcomas (18). The use of hypermutable
polymorphic marker DXS981, employed in the last study, did
not show any advantage over other microsatellite markers.
The generation of new alleles at microsatellite loci is
probably due to slipped-strand mispairing (19-21). Although
it is currently unknown why some loci are hypermutable,
nucleotide sequence comparisons of these loci may reveal
sequences that predispose to, or promote the genesis of,
new alleles.
The study of the origin of new alleles of marker D21S1245
revealed that the larger alleles were more prone to instability
(expansion or contraction). This is similar to the trinucleotide
repeat expansion in fragile X syndrome, Huntington disease
and similar disorders in which alleles of the premutation size
undergo trinucleotide expansion to the full mutation range,
whereas alleles of the normal size range do not (13).
MATERIALS AND METHODS
Cloning of polymorphic SSR
The cloning of the polymorphic DNA fragments was performed in the
laboratory of R.W. as follows: human male DNA was digested with with
5au3AI, end-filled with dG and dA, and size-fractionated on a 1% agarose
gel. DNA fragments ranging from 300 to 700 bp were subcloned into the dC,
dT end-filled Sal] site of M13mpl8. Libraries were screened with end-labeled
oligonucleotide probes |e.g. (GT)|5, (AGAT)5, (AAAG)5] for recombinant
clones containing SSRs. Nucleotide sequences of positive clones were deter-
mined using the ABI373 automated sequencer. Oligonucleotide primers were
made to develop STSs (sequence tagged sites) for the clones containing long
repeats. STS that were polymorphic in eight unrelated CEPH parents were
used for genotyping in the CEPH families (22,23). STS were mapped to
single human chromosomes using the monochromosomal NIGMS mapping
panel 2 (24).
Linkage mapping
Information on DNA markers that mapped to human chromosome 21 was
provided to the laboratory of S.E.A. Genotypes were generated in the DNA
of lymphoblastoid cell lines of members of CEPH pedigrees by PCR. The
following eight most informative CEPH pedigrees (102, 884, 1331, 1332,
1347, 1362, 1413, 1416) were genotyped for all markers with the exception
of locus D2IS1245, which was genotyped using the lymphoblastoid cell line
DNAs from members of all 40 CEPH pedigrees. PCR amplification was
performed as follows: 200 ng of template DNA was amplified in a total
volume of 25 ul consisting of 1.5 mM MgCl2, 50 mM KCI, 10 mM Tris (pH
8.3), 200 |iM of each dNTP, 0.4 |iM of each primer and 0.5 U Taq polymerase.
One oligonucleotide primer was 32P radiolabeled using the T4 kinase reaction.
The PCR amplification consisted of an initial denaturation of 94°C for 6 min,
followed by 30 cycles of denaturation at 94°C/30 s, annealing at 50-60°C/30
s (varied according to the oligonucleotide pair) and extension at 72°C/30 s
using either MJ. Research PTC-100-96 or Perkin-Elmer-Cetus 480 thermo-
cyclers. The PCR products were separated by electrophoresis in 6% poly-
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acrylamide/50% urea gel and the dried gels exposed to X-ray film for 2-24
h. Genotypes were determined by two independent readings and entered into
our database. In the most recent phase of the project genotypes were determined
after electrophoresis of ftuorescently labeled PCR products on an ABI373
sequencer. The analysis of the polymorphic alleles was performed using the
GENESCAN 672 software (25). Data were transferred electronically to the
laboratory of A.C. for linkage mapping. The positions of the new loci in the
existing linkage map of chromosome 21 (6) were determined using the
program MULTIMAP as described by Matise et al. (5). Locus order and map
distances were validated using the program package LINKAGE (26). A more
detailed description of the mapping algorithm and the routines for error
checking can be found in Mclnnis et al. (6).
Nucleotide sequencing of PCR products of specific alleles of locus
D21S1245 was performed as follows: the product of an unlabeled PCR was
electrophoresed on a 8% non-denaturing acrylamide gel and the amplified
alleles, visualized by ethidium bromide under UV, were separately excised
from the gel and recovered by electroelution. A purified single allele's DNA
was then used as template for a second round of PCR, the product of which
was checked for extra-allelic contamination and purified with a 3%:1%
Nusieve/agarose gel and then sequenced using fluorescent dideoxy terminator
cycle sequencing on an ABI373 automated DNA sequencer as described
(27,28).
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